Correlation Between Exelixis and Sarepta Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Exelixis and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Sarepta Therapeutics, you can compare the effects of market volatilities on Exelixis and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Sarepta Therapeutics.

Diversification Opportunities for Exelixis and Sarepta Therapeutics

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Exelixis and Sarepta is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of Exelixis i.e., Exelixis and Sarepta Therapeutics go up and down completely randomly.

Pair Corralation between Exelixis and Sarepta Therapeutics

Given the investment horizon of 90 days Exelixis is expected to generate 1.11 times more return on investment than Sarepta Therapeutics. However, Exelixis is 1.11 times more volatile than Sarepta Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Sarepta Therapeutics is currently generating about -0.09 per unit of risk. If you would invest  3,348  in Exelixis on October 23, 2024 and sell it today you would earn a total of  295.00  from holding Exelixis or generate 8.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Exelixis  vs.  Sarepta Therapeutics

 Performance 
       Timeline  
Exelixis 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Exelixis disclosed solid returns over the last few months and may actually be approaching a breakup point.
Sarepta Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sarepta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Exelixis and Sarepta Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Exelixis and Sarepta Therapeutics

The main advantage of trading using opposite Exelixis and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.
The idea behind Exelixis and Sarepta Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Transaction History
View history of all your transactions and understand their impact on performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments